This week in one minute
A mid-week AI selloff, then a Micron-driven rebound, while banks opened the capital-return spigot.
The week started rough for technology. Memory and semiconductor shares were routed Monday and Tuesday, and Apple fell about 6.5% after CEO Tim Cook called rising memory costs 'unavoidable.' Then Micron reported a blowout quarter Wednesday after the close, with revenue up roughly 346% year over year on AI memory demand, and the AI trade roared back Thursday as the Nasdaq rose more than 2%. Separately, all 32 major banks passed the Fed's annual stress test, clearing the way for dividend increases and buybacks, and the Dow pushed to a fresh record. The net result was a choppy but ultimately constructive week in which leadership broadened beyond mega-cap software into memory, financials, and healthcare M&A. Prices in this issue reflect closes through Friday, June 26, 2026.
Market Risk Score: 58 / 100. Neutral, leaning constructive.
The risk score grades overall market conditions from 0 (calm) to 100 (high risk). It sets how cautious the week's read is. It is not a signal to buy or sell anything.
This week's five
MU · Micron Technology · Technology / Memory
Fiscal Q3 blew past estimates: revenue near $41.5B against roughly $35.7B expected, adjusted EPS of $25.11 versus about $20.49, with revenue up roughly 346% year over year on AI memory (high-bandwidth memory and advanced DRAM). Management pointed to around $22B in customer supply commitments and guided Q4 revenue to about $50B. Bear case: the stock has run hard in 2026 and memory remains deeply cyclical, so a single guide-down can reset it quickly.
SNDK · SanDisk · Technology / NAND Storage
A NAND memory play riding two tailwinds: Apple's Tim Cook calling memory price hikes 'unavoidable,' and Micron's blowout confirming the upcycle. Shares are up more than 600% in 2026. Bear case: that parabolic move is the risk. Memory pricing is cyclical, the valuation is stretched, and the pending Western Digital share-swap adds an overhang.
APGE · Apogee Therapeutics · Healthcare / Biotech
Two catalysts in one week: a strong Phase 2 atopic dermatitis readout (a 65.9% EASI-75 response at the selected dose) and an announced acquisition by AbbVie at $135.11 per share, a roughly 49% premium, alongside up to $1.3B in Blackstone financing. Bear case: with a deal price set, most of the upside is already in the stock. This is now effectively a merger-arbitrage situation, and biotech deals still carry regulatory and closing risk.
JPM · JPMorgan Chase · Financials / Banks
Passed the Fed's annual stress test and moved immediately to return capital: a new $50B buyback authorization and a dividend increase to $1.65 per quarter from $1.50. Bear case: capital return was widely expected, so this is more confirmation than surprise, and large banks remain sensitive to credit conditions and the path of interest rates.
MS · Morgan Stanley · Financials / Banks
Also cleared the stress test and announced the group's biggest dividend hike, up 15% to $1.15 per quarter, plus a reauthorized $20B buyback. Bear case: Morgan Stanley leans on capital markets and wealth flows, so a slowdown in deal and trading activity would pressure results, and the capital-return theme was already partly priced in.
Premium Members'
Stock of the week
Micron Technology (MU)
If you remember one name this week, make it Micron. It is the clearest, most measurable expression of the AI memory upcycle: a verified earnings beat, roughly 346% revenue growth, about $22B in customer commitments, and a Q4 guide near $50B. It sits squarely in the week's leading theme, and the catalyst is concrete rather than narrative. The risk is simply how far and how fast it has already run, which is exactly why entry discipline matters.
Sector rotation
Into: Semiconductors / Memory · Financials (banks) · Healthcare (M&A)
Out of: Mega-cap software · Consumer tech hardware (Apple) · Energy
Rotation is money moving between industry groups. It shows where big investors added this week and where they pulled back.
Next week's watch
- PCE inflation print and the Fed's reaction
- Whether the memory upcycle rally holds or fades
- Bank capital-return follow-through
- The 10-year Treasury yield path
- The start of Q2 earnings season
- Oil and energy prices
Terms in this issue
Cyclical stock. A company whose profits swing with a repeating boom and bust cycle rather than growing steadily. Memory makers like Micron are classic cyclicals, which is why a blowout quarter can still land near a peak. More in the Learn hub →
Merger arbitrage. Buying a stock after a takeover is announced to capture the small gap between the market price and the agreed deal price. Once a price is set, most of the upside is already gone. More in the Learn hub →
Stress test. The Federal Reserve annual check of whether big banks hold enough capital to survive a severe recession. Passing clears them to raise dividends and buy back stock. More in the Learn hub →
Year over year. A comparison of a result to the same period a year earlier, which strips out seasonal swings. Revenue up 346% year over year means versus the same quarter last year.
Buyback. When a company repurchases its own shares, shrinking the share count and lifting earnings per share. Banks announced large buybacks after clearing the stress test.
Guidance. Management own forecast for the next quarter or year. Markets often react more to guidance than to the results just reported, because price reflects the future.